J. Moore

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

Medicine, Oncology, Pharmacology +17

Hyperthermic Oncology 1984

Helen R. Griffiths, J. Moore · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · 1985 · 526 citations

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn et al. · PubMed · 1999 · 300 citations

Medicine, Oncology, Pharmacology +16

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Z Arlin, Delvyn C. Case, J. Moore et al. · PubMed · 1990 · 199 citations

Medicine, Hematology, Oncology +12

A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily

Philip Savage, Vicki L. Horton, J. Moore et al. · British Journal of Cancer · 1996 · 108 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11